Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · IEX Real-Time Price · USD

33.88

+0.59 (1.77%)

At close: Jul 19, 2024, 4:00 PM

34.20

+0.32 (0.94%)

Pre-market: Jul 22, 2024, 9:02 AM EDT

Corcept Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2001
Net Income	117.19	105.5	101.29	112.51	106.01	94.18	Upgrade
Depreciation & Amortization	1.8	2.36	3.45	3.48	2.24	2.17	Upgrade
Share-Based Compensation	51.05	48.94	42.44	42.93	33.54	29.31	Upgrade
Other Operating Activities	-45.2	-29.76	-26.85	8.97	10.18	10.45	Upgrade
Operating Cash Flow	124.84	127.04	120.32	167.89	151.97	136.12	Upgrade
Operating Cash Flow Growth	12.43%	5.58%	-28.33%	10.48%	11.65%	17.68%	Upgrade
Capital Expenditures	-0.14	-0.14	-0.41	-0.47	-1.24	-1.09	Upgrade
Change in Investments	-125.44	91.05	-113.91	136.6	-118.03	-116.74	Upgrade
Investing Cash Flow	-125.58	90.91	-114.33	136.13	-119.26	-117.83	Upgrade
Share Issuance / Repurchase	-149.45	-148.72	-17.28	-302.59	12.21	-28.65	Upgrade
Financing Cash Flow	-149.45	-148.72	-17.28	-302.59	12.21	-28.65	Upgrade
Net Cash Flow	-150.19	69.22	-11.29	1.43	44.92	-10.36	Upgrade
Free Cash Flow	124.7	126.9	119.91	167.42	150.73	135.03	Upgrade
Free Cash Flow Growth	12.72%	5.83%	-28.38%	11.07%	11.63%	17.04%	Upgrade
Free Cash Flow Margin	23.82%	26.31%	29.84%	45.75%	42.59%	44.06%	Upgrade
Free Cash Flow Per Share	1.21	1.23	1.12	1.45	1.31	1.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).